If, for a patient 46,XX DSD, congenital adrenal hyperplasia was excluded, the molecular studies mainly target the genes SRY, SOX9, SOX3, SOX10, RSPO1, or WNT4. The gene discussed is SOX3; the disease is disorder of sexual differentiation.